New drug combo shows promise for advanced gallbladder cancer
NCT ID NCT07099547
First seen May 05, 2026 · Last updated May 05, 2026
Summary
This study tests a new drug called ZG005 combined with standard chemotherapy (gemcitabine and cisplatin) as a first treatment for people with advanced gallbladder cancer. The goal is to see if the combination shrinks tumors better than chemo alone. About 60 participants will take part, and the study will also monitor side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY TRACT CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of University of Science and Technology of China
RECRUITINGHefei, Anhui, 230001, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.